Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosdorbank plans FPO

6/27/24 RDRB

Buryatzoloto adjusted RAS for the 1st quarter

6/27/24 BRZL

Shareholders of Mobile TeleSystems approved dividends for 2023

6/27/24 MTSS

Shareholders of Tatneft approved dividends for 2023

6/27/24 TATN

Board of Directors of Bashinformsvyaz recommended that dividends be paid for 2023

6/27/24 BISVP

Shareholders of Rosseti Moscow Region approved dividends for 2023

6/27/24 MSRS

Softline will place an additional share issue for M&A financing

6/27/24 SOFL

Novatek plans to ship Line 2 for Arctic LNG-2 at the end of July

6/27/24 NVTK

Nextgen to launch medical tourism program

6/27/24 ABIO

Diasoft reported for 2023 by IFRS

6/27/24 DIAS